125459

: This guideline is a cornerstone for developers of Advanced Therapy Medicinal Products (ATMPs) in the European Union.

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .

: Determining where the therapeutic gene goes in the body and how long it persists in both target and non-target cells. 125459

This document outlines the essential safety and efficacy data that developers must generate during the "non-clinical" (animal or lab) phase to justify moving into human subjects.

: Checking if the patient might "shed" or spread the virus/vector through secretions. : This guideline is a cornerstone for developers

: Defining scientific principles for non-clinical studies specifically for gene therapies, which differ significantly from conventional pharmaceuticals. Key Safety Requirements :

Guideline on the Non-Clinical Studies Required before First ... - EMA This document outlines the essential safety and efficacy

: Evaluating whether the viral vector or therapeutic gene could unintentionally be passed on to future generations.